Large integrated data advantage QuantHealth maintains one of the largest integrated datasets across clinical, pharmacological, and biological domains, enabling fast, scalable patient-response simulations that can de-risk and accelerate partner drug programs.

High trial optimization value The platform enables rapid exploration of thousands of trial variations to optimize design, potentially improving success probability and reducing development timelines for pharma and biotech partners.

Addressing high failure cost With over 90% of drugs failing in clinical development and a $45B/year direct loss, QuantHealth offers a compelling ROI by shortening timelines and improving decision confidence for asset progression.

Enterprise collaboration fit Target pharma and biotech organizations looking to de-risk pipelines, accelerate go/no-go decisions, and uncover new clinical opportunities through AI-driven patient-response predictions.

Scale-ready platform Operating from Tel Aviv with a mid-sized team, QuantHealth presents a scalable AI platform and potential for partnerships that can expand data coverage and trial simulation capacity as customers grow.